Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2014-01-14
AEs
2
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild TRANSIENT ISCHAEMIC ATTACK — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-16 (study day 3.0); relationship: REMOTE; serious criteria: hospitalization
mild
assessed
Mild TRANSIENT ISCHAEMIC ATTACK — outcome: RECOVERED/RESOLVED; onset 2014-01-16 (study day 3.0); relationship: REMOTE; serious criteria: hospitalization
Data queries
No data queries.